Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases-Reference-Cited by-同舟云学术

Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases

Published:2020-06-19 Issue:13 Volume:11 Page:1937-1943
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Al-Awadhi Fatma H.¹²,Salvador-Reyes Lilibeth A.¹³,Elsadek Lobna A.¹,Ratnayake Ranjala¹,Chen Qi-Yin¹,Luesch Hendrik¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development, University of Florida, 1345 Center Drive, Gainesville 32610, Florida, United States

2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait

3. Marine Science Institute, College of Science, University of the Philippines, Diliman, Quezon City 1100, Philippines

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00093

Reference43 articles.

1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

2. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells

3. Expression profile of class I histone deacetylases in human cancer tissues

4. Histone Deacetylase Inhibitors as Anticancer Drugs

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-08-24

3. Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options;Cancers;2023-04-27

4. Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials;Molecules;2023-01-09

5. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors;Advances in Cancer Research;2023